Myogenic progenitor cells exhibit IFN type I-driven pro-angiogenic properties and molecular signature during juvenile dermatomyositis
Arthritis & Rheumatism Sep 29, 2017
Gitiaux C, et al. - This study examined the hypothesis that myogenic precursor cells (MPCs) could modulate vascular remodeling /angiogenesis during juvenile dermatoMyositis (JDM). These outcomes show a new type I Interferon (IFN-I) pathway in JDM, which activates the production of angiogenic effectors by MPCs, triggering their pro-angiogenic function to promote vessel recovery and muscle reconstruction.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries